{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:54:51Z","timestamp":1790765691215,"version":"4.1.0"},"reference-count":17,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Type 2 myocardial infarction (T2MI) results from a myocardial oxygen supply\u2013demand imbalance without acute coronary atherothrombosis, and the role of invasive coronary angiography in its management is undefined. Prior literature has largely compared T2MI to type 1 myocardial infarction (T1MI) rather than examining angiography selection within T2MI itself. This systematic review with narrative synthesis identified and synthesized factors associated with angiography utilization among T2MI patients, distinguishing adjusted from unadjusted evidence. Methods: PubMed, Embase, and ClinicalTrials.gov were searched for studies reporting patient or clinical characteristics associated with undergoing invasive coronary angiography among patients with T2MI, identified via multivariable regression, univariate comparison, or stratified baseline tables. Studies using angiography as an inclusion criterion, an event-risk outcome, or a randomized treatment assignment, or comparing T2MI to T1MI as groups without addressing within-T2MI factors, were excluded. This review was conducted in accordance with PRISMA 2020 guidance. Given clinical and methodological heterogeneity and no common effect-size metric across studies, findings were synthesized narratively without quantitative pooling. Results: Three studies met inclusion criteria (two large US administrative-data cohorts, n = 268,850 and n = 18,606 T2MI; one French two-center cohort, n = 224). Younger age was independently associated with greater odds of angiography in the largest cohort reporting age-specific estimates, with a monotonic decline in angiography utilization across advancing age strata; a second cohort\u2019s unadjusted group comparison was directionally concordant, but its own multivariable estimate for age was internally inconsistent and is not treated as confirmatory. Chronic ischemic heart disease and heart failure were independently associated with higher odds of angiography, while chronic kidney disease, chronic obstructive pulmonary disease, peripheral vascular disease, and atrial fibrillation were independently associated with lower odds. Commercial insurance and Midwest or South United States residence were independently associated with higher odds in the single study assessing these factors. Cardiology consultation showed conflicting directions of adjusted association between the two studies reporting it. Conclusions: Selection for invasive angiography in T2MI is heterogeneous and inconsistently studied. Age was the only factor with cross-study directional support, and even that lacked confirmed adjusted concordance. Other factors were supported by single studies or conflicting findings, and no included study reported the bedside clinical variables plausibly driving real-time decisions. Certainty was very low for every factor examined (modified GRADE), underscoring the need for prospective study of angiography selection in T2MI.<\/jats:p>","DOI":"10.3390\/jcm15197586","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:25:42Z","timestamp":1790760342000},"page":"7586","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with Invasive Coronary Angiography Use in Type 2 Myocardial Infarction: A Systematic Review with Narrative Synthesis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1464-328X","authenticated-orcid":false,"given":"Ngoc Thai","family":"Kieu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mays","family":"Tawayha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Yaqub","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noman","family":"Chaudhary","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Katib","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, HCA Florida Aventura Hospital and Nova Southeastern University, Aventura, FL 33180, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Mosleh","sequence":"additional","affiliation":[{"name":"Department of Interventional Cardiology, Mercy Hospital of Buffalo, University at Buffalo, Buffalo, NY 14220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5334\/gh.1578","article-title":"Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction","volume":"21","author":"Mills","year":"2026","journal-title":"Glob. Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MCA.0000000000001122","article-title":"Patterns and Outcomes of Invasive Management of Type 2 Myocardial Infarction in the United States","volume":"33","author":"Smilowitz","year":"2022","journal-title":"Coron. Artery Dis."},{"key":"ref_4","first-page":"e83137","article-title":"Diagnosis and Management of Type 2 Acute Coronary Syndrome in Patients Without Pre-existing Cardiomyopathy in Centers With and Without Percutaneous Coronary Intervention","volume":"17","author":"Fournier","year":"2025","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101629","DOI":"10.1016\/j.jacadv.2025.101629","article-title":"Utilization of Cardiovascular Procedures, Consultation Services, and Cardioprotective Medications Among Type 2 Myocardial Infarction Patients","volume":"4","author":"Goel","year":"2025","journal-title":"JACC Adv."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third Universal Definition of Myocardial Infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing Bias in Studies of Prognostic Factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","article-title":"Rating the Certainty in Evidence in the Absence of a Single Estimate of Effect","volume":"22","author":"Murad","year":"2017","journal-title":"Evid. Based Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(20)30930-2","article-title":"Invasive Versus Non-Invasive Management of Older Patients with Non-ST Elevation Myocardial Infarction (SENIOR-NSTEMI): A Cohort Study Based on Routine Clinical Data","volume":"396","author":"Kaura","year":"2020","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jcmg.2011.12.016","article-title":"Angiographic Correlates in Type 1 and 2 MI by the Universal Definition","volume":"5","author":"Ambrose","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.281.7.627","article-title":"Geographic Variation in the Treatment of Acute Myocardial Infarction: The Cooperative Cardiovascular Project","volume":"281","author":"Quinton","year":"1999","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archinte.160.6.817","article-title":"Payer Status and the Utilization of Hospital Resources in Acute Myocardial Infarction: A Report from the National Registry of Myocardial Infarction 2","volume":"160","author":"Canto","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/clc.22250","article-title":"Regional Variation Across the United States in Management and Outcomes of ST-Elevation Myocardial Infarction: Analysis of the 2003 to 2010 Nationwide Inpatient Sample Database","volume":"37","author":"Kolte","year":"2014","journal-title":"Clin. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ahj.2018.09.016","article-title":"The Appropriateness of Coronary Investigation in Myocardial Injury and Type 2 Myocardial Infarction (ACT-2): A Randomized Trial Design","volume":"208","author":"Lambrakis","year":"2019","journal-title":"Am. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101738","DOI":"10.1016\/j.jacadv.2025.101738","article-title":"Targeting Investigation and Treatment in Type 2 Myocardial Infarction: A Pilot Randomized Controlled Trial","volume":"4","author":"Taggart","year":"2025","journal-title":"JACC Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/eurheartj\/ehae803","article-title":"Type 2 Myocardial Infarction: Challenges in Diagnosis and Treatment","volume":"46","author":"Chapman","year":"2025","journal-title":"Eur. Heart J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7586\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:55:12Z","timestamp":1790762112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":17,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197586"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197586","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}